Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-02

Clinical Trial Update: Incisional Negative Pressure Wound Therapy to Reduce Infection and Complications in High-Risk Fractures [Phase 3]

View source ↗

Summary

This Phase 3 clinical trial is evaluating incisional negative pressure wound therapy to reduce infection and complications in high-risk tibial fractures.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Incisional negative pressure wound therapy

Snippet

Sponsor: Major Extremity Trauma Research Consortium | Conditions: Fracture of Tibia, Wound Heal | Phase 3 | Status: RECRUITING